Nanotechnology Drug Delivery
mainly used in healthcare applications such as such as neurology, anti-infective, cardiovascular disorders, and others. They are part of active application of the transport drugs to the final location of therapeutic intervention within the body. Globally, development of efficient and advance technology, expanding nanotechnology research, growing awareness among common people, increasing government initiatives, and rising demand for novel drug delivery are the prime growth drivers of global Nanotechnology Drug Delivery market. In addition, increase in adoption of Nanotechnology Drug Delivery for in emerging economies such as China, India and others, will create new opportunities for global Nanotechnology Drug Delivery market. However, higher cost of the research and development, high cost of production with stringent regulatory scenario are the key restraints for global Nanotechnology Drug Delivery market.
Geographically North America dominated
global Nanotechnology Drug Delivery market
, because of high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have fastest growth, owing to rapidly increasing population, rise in consumer awareness, favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the application, neurology procedures has the highest market share in global Nanotechnology Drug Delivery market.
This report identifies the global Nanotechnology Drug Delivery market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global Nanotechnology Drug Delivery market.
This report segments global Nanotechnology Drug Delivery market on the basis of technology, application, and regional market as follows:
- Nanotechnology Drug Delivery Market, By Technology: Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, and Others
- The report has focused study on Nanotechnology Drug Delivery market by application: Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, and Others
- This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
Sample Companies Profiled in this Report are:
- AbbVie, Inc
- Amgen, Inc
- Celgene Corporation
- Johnson & Johnson
- Merck & Co., Inc.